Enterin announces FDA acceptance of an in... - Cure Parkinson's

Cure Parkinson's

25,550 members • 26,870 posts

Enterin announces FDA acceptance of an investigator sponsored IND to treat a patient with prodromal multisystem-atrophy MSA with ENT-01

LeharLover62•

9 months ago•0 Replies

I wish the FDA allowed this option to be available to more people who are getting into advanced stages of disease.

parkinsonsnewstoday.com/new...

I hadn’t heard much about the squalamine trial lately, but apparently it’s close to entering phase 3.

Written by

LeharLover62

To view profiles and participate in discussions please or .

You may also like...

Houston Research Organization Successfully Treats 24 Patients in FDA-Authorized Parkinson’s Study

In this Phase II, double blind, placebo-controlled study, 24 patients received six intravenous...

Farooqji•1 year ago

Decreasing dopamine treatment levels In late stage Parkinson’s disease.

decreasing dopamine treatments is a proper method for a patient exhibiting a deteriorating clinical...

BoBo9-Breeze•1 year ago

Another Study Finds A Link Between Covid-19 and Parkinson's Disease

Covid-19 may provide benefits to Parkinson's patients and vice versa....

jimcaster•1 year ago

Tremor-experience in using Cala Trio

tremors at the right side I heard about Cala Trio I’m asking for any pd patient for his self...

Bari2000•2 years ago

GOOD NEWS! PwP achieved GREAT improvement with...

\\"Patients with Parkinson's disease achieved a significant improvement in their tremors,...

PDWarrior1900•1 year ago